MedTrace Logo

People Bereaved by Violent Death : Negative Event Biases and Temporal Perception

NCT05874362 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2025-03-06

No results posted yet for this study

Summary

A violent death is defined by its brutality, unexpectedness and is secondary to an external cause (suicide, homicide, accident). Bereavement following a violent death constitutes a particular clinical situation, at risk of complications. Research on bereavement after a violent death shows higher risks of psychiatric and somatic complications than in bereavement by non-violent death. These complications, sometimes comorbid, take the form of depressive episodes, post-traumatic stress disorders, suicidal behavior and prolonged grief disorders after 12 months, precociously mediated by ruminations.

Processes responsible for this increased risk of complications are poorly documented. Current literature relates mainly to socio-demographic and epidemiological factors which, alone, do not explain this difference in risks. Further research is needed exploring other kinds of data and processes. To our knowledge, there is no description of early neurocognitive functioning in people bereaved after violent death. This study aims at exploring early neurocognitive processes which can lead to complications in people bereaved by violent death.

Conditions

  • Post Traumatic Stress Disorder

Interventions

OTHER

Diagnosis of depressive episode or post traumatic stress disorder

Clinical diagnosis of depressive episode or post traumatic stress disorder, confirmed

OTHER

No diagnosis of depressive episode or post traumatic stress disorder

No elements in clinical assessment for the diagnosis of a depressive episode or post traumatic stress disorder

Sponsors & Collaborators

  • Hôpital le Vinatier

    lead OTHER

Principal Investigators

  • Edouard LEAUNE · Vinatier Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-19
Primary Completion
2026-02-28
Completion
2026-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05874362 on ClinicalTrials.gov